Cytokines, bone remodeling, and estrogen deficiency: A 1998 update

Bone

Volumn 23, Issue 2, 1998, Pages 75-81

  Jilka, Robert L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; ESTROGEN; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; BONE MARROW CULTURE; BONE MARROW DEPRESSION; BONE REMODELING; CELL COUNT; CELL DIFFERENTIATION; COLONY FORMING UNIT GM; ESTROGEN DEFICIENCY; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; OVARIECTOMY; REVIEW;

APOPTOSIS; BONE DISEASES, METABOLIC; BONE REMODELING; CYTOKINES; ESTROGENS; FEMALE; HUMANS; OSTEOBLASTS; OSTEOCLASTS;

EID: 0032145401     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00077-5     Document Type: Review

References (85)

1. 1. Ammann, P., Rizzoli, R., Bonjour, J. P., Bourrin, S., Meyer, J. M., Vassalli, P., and Garcia, I. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 1699:1699-1703; 1997.
2. 2. Bagby, Jr. G. C. Hematopoiesis. In: Stamatoyannopoulos, G., Nienhuis, A. W., Majerus, P. W., and Varmus, H., Eds. The Molecular Basis of Blood Diseases. Philadelphia: Saunders; 1994; 71-103.
3. 3. Balena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., Frankenfield, D., Quartuccio, H., Fioravanti, C., Clair, J., Brown, E., Hayes, W. C., and Rodan, G. A. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577-2586; 1993.
4. 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats. J Bone Miner Res 10:971-977; 1995.
5. 5. Bellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H., Dalrymple, S. A., Murray, R., and Manolagas, S. C. Regulation of interleukin-6, osteoclastogenesis and bone mass by androgens: The role of the androgen receptor. J Clin Invest 95:2886-2895; 1995.
6. 6. Bonewald, L. F. and Mundy, G. R. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 250:261-276; 1990.
7. 7. Bismar, H., Diel, I., Ziegler, R., and Pfeilschifter, J. Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351-3355; 1995.
8. 8. Cavolina, J. M., Evan, G., Harris, S. A., Zhang, M., Westerlind, K. C., and Turner, R. T. The effects of orbital spaceflight on bone histomorphometry and messenger ribonucleic acid levels for bone matrix proteins and skeletal signaling peptides in ovariectomized growing rats. Endocrinology 138:1567-1576; 1997.
9. 9. Cheleuitte, D., Mizuno, S., and Glowacki, J. In vitro secretion of cytokines by human bone marrow: Effects of age and estrogen status. J Clin Endocrinol Metab 83:2043-2051; 1998.
10. 10. De La Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., and Roodman, G. D. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95: 2846-2852; 1995.
11. 11. Dinarello, C. A. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147; 1996.
12. 12. Ducy, P., Zhang, R., Goeffroy, V., Ridall, A. L., and Karsenty, G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754; 1997.
13. 13. Erlebacher, A. and Derynck, R. Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210; 1996.
14. 14. Felix, R., Hofstetter, W., Wetterwald, A., Cecchini, M. G., and Fleisch, H. Role of colony-stimulating factor-1 in bone metabolism. J Cell Biochem 55:340-349; 1994.
15. 15. Finkelman, R. D., Bell, N. H., Strong, D. D., Demers, L. M., and Baylink, D. J. Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: Implications for estrogen deficiency-associated bone loss. Proc Natl Acad Sci USA 89:12190-12193; 1992.
16. 16. Franchimont, N., Rydziel, S., and Canalis, E. Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest 100:1797-1803; 1997.
17. 17. Galien, R., Evans, H. F., and Garcia, T. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappaB binding sites in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol 10:713-722; 1996.
18. 18. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., and Manolagas, S. C. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in-vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891; 1992.
19. 19. Glasebrook, A. L., Short, L. L., Cole, H. W., Sato, M., and Bryant, H. U. Regulation of serum IL-6 by raloxifene in an ovx rat model. Bone 16:99S; 1995.
20. 20. Gowen, M. and Mundy, G. R. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 136:2478-2482; 1986.
21. 21. Han, Z. H., Palnitkar, S., Rao, D. S., Nelson, D., and Parfitt, A. M. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss. J Bone Miner Res 12:498-508; 1997.
22. 22. Hughes, D. E. and Boyce, B. F. Apoptosis in bone physiology and disease. J Clin Pathol Clin Mol Pathol 50:132-137; 1997.
23. 23. Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., and Boyce, B. F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nature Med 2:1132-1136; 1996.
24. 24. Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., Kishimoto, T., and Suda, T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303; 1990.
25. 25. Jacobsen, F. W., Stokke, T., and Jacobsen, S. E. W. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood 86:2957-2966; 1995.
26. 26. Jilka, R. L. and Hamilton, J. A. Inhibition of parathormone-stimulated bone resorption by Type I interferon. Biochem Biophys Res Commun 120:553-558; 1984.
27. 27. Jilka, R. L., Hangoc, G., Girasole, G., Passen, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., and Manolagas, S. C. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91; 1992.
28. 28. Jilka, R. L. and Manolagas, S. C. The cellular and biochemical basis of bone remodeling. In: Marcus, R., Ed. Osteoporosis. Cambridge, MA: Blackwell; 1994:17-48.
29. 29. Jilka, R. L., Passeri, G., Girasole, G., Cooper, S., Abrams, J., Broxmeyer, H., and Manolagas, S. C. Estrogen loss upregulates hematopoiesis in the mouse: A mediating role of interleukin-6. Exp Hematol 23:500-506; 1995.
30. 30. Jilka, R. L., Takahashi, K., Munshi, M., Williams, D. C., Roberson, P. K., and Manolagas, S. C. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: Evidence for autonomy from factors released during bone resorption. J Clin Invest. 101:1942-1950; 1998.
31. 31. Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., and Manolagas, S. C. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest 97:1732-1740; 1996.
32. 32. Jimi, E., Ikebe, T., Takahashi, N., Hirata, M., Suda, T., and Koga, T. Interleukin-1α activates all NF-kappaB-like factor in osteoclast-like cells. J Biol Chem 271:4605-4608; 1996.
33. 33. Jimi, E., Nakamura, I., Ikebe, T., Takahashi, N., and Suda, T. IL-1 induces survival of osteoclasts by activating NF-kB. J Bone Miner Res 12:S148; 1997.
34. 34. Kameda, T., Mano, H., Yuasa, T., Mori, Y., Miyazawa, K., Shiokawa, M., Nakamaru, Y., Hiroi, E., Hiura, K., Kameda, A., Yang, N. N., Hakeda, Y., and Kumegawa, M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489-495; 1997.
35. 35. Kasono, K., Sato, K., Sato, Y., Tsushima, T., Shizume, K., and Demura, H. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. Bone Miner 21:179-188; 1993.
36. 36. Kassem, M., Harris, S. A., Spelsberg, T. C., and Riggs, B. L. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res 11:193-199; 1996.
37. 37. Kassem, M., Khosla, S., Spelsberg, T. C., and Riggs, B. L. Cytokine production in the bone marrow microenvironment: Failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab 81:513-518; 1996.
38. 38. Keller, E. T., Chang, C. S., and Ershler, W. B. Inhibition of NFkappaB activity through maintenance of IkappaBα levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 271:26267-26275; 1996.
39. 39. Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., and Pacifici, R. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061; 1995.
40. 40. Kimble, R. B., Srivastava, S., and Pacifici, R. Estrogen inhibits macrophage TNF gene expression by modulating binding of transcription factors to the AP-1 binding site. J Bone Miner Res 12(Suppl. 1):S441; 1997.
41. 41. Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., and Pacifici, R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1-and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem 271:28890-28897; 1996.
42. 42. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., Sato, M., Okamoto, T., Kitamura, Y., Yoshiki, S., and Kishimoto, T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764; 1997.
43. 43. Kurebayashi, S., Miyashita, Y., Hirose, T., Kasayama, S., Akira, S., and Kishimoto, T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J Steroid Biochem Mol Biol 60:11-17; 1997.
44. 44. Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.-X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation. Cell 93:1-20; 1998.
45. 45. Lagasse, E. and Weissman, I. L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021-1031; 1997.
46. 46. Lin, S. C., Yamate, T., Taguchi, Y., Borba, V. Z., Girasole, G., O'Brien, C. A., Bellido, T., Abe, E., and Manolagas, S. C. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest 100:1980-1990; 1997.
47. 47. Lorenzo, J., Naprta, A., Rao, Y., Alander, C., Glaccum, M., Gronowicz, G., Kalinowski, J., and Pilbeam, C. Mice deficient in the functional interleukin-1 receptor I (IL-1R1) do not lose bone mass after ovariectomy. J Bone Miner Res 12(Suppl. 1): S126; 1997.
48. 48. Lotem, J. and Sachs, L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 10:925-931; 1996.
49. 49. Lutton, J. D., Moonga, B. S., and Dempster, D. W. Osteoclast demise in the rat: Physiological versus degenerative cell death. Exp Physiol 81:251-260; 1996.
50. 50. Manolagas, S. C., Jilka, R. L., Bellido, T., O'Brien, C. A., and Parfitt, A. M. Interleukin-6-type cytokines and their receptors. In: Bilezikian, J. P., Raisz, L. G., and Rodan, G. A., Eds. Principles of Bone Biology. San Diego: Academic; 1996; 701-713.
51. 51. Martin, T. J. and Ng, K. W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357-366; 1994.
52. 52. Matsumoto, H. N., Tamura, M., Denhardt, D. T., Obinata, M., and Noda, M. Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis. Endocrinology 136:4084-4091; 1995.
53. 53. Miyaura, C., Kusano, K., Masuzawa, T., Chaki, O., Onoe, Y., Aoyagi, M., Sasaki, T., Tamura, T., Koishihara, Y., Ohsugi, Y., and Suda, T. Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6. J Bone Miner Res 10:1365-1373; 1995.
54. 54. Nuttall, M. E., Nadeau, D., Prichett, W. P., and Gowen, M. Idoxifene, a tissue selective estrogen agonist/antagonist, has a mechanism of action in bone similar to estrogen and distinct from raloxifene. J Bone Miner Res 12:S170; 1997.
55. 55. O'Brien, C. A., Jilka, R. L., and Manolagas, S. C. Generation of mice harboring an IL-6 promoter-luciferase transgene that mimics endogenous IL-6 gene regulation. J Bone Miner Res 12:S435; 1997.
56. 56. O'Brien, C. A. and Manolagas, S. C. Isolation and characterization of the human gp130 promoter - Regulation by STATS. J Biol Chem 272:15003-15010; 1997.
57. 57. Ogasawara, H., Tsuji, T., Hirano, D., Aoki, Y., Nakamura, M., and Kodama, H. Induction of IL-6 production by bone marrow stromal cells on the adhesion of IL-6-dependent hematopoietic cells. J Cell Physiol 169:209-216; 1996.
58. 58. Owens, J. M., Gallagher, A. C., and Chambers, T. J. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 157:936-940; 1996.
59. 59. Parfitt, A. M. Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55:273-286; 1994.
60. 60. Passen, G., Girasole, G., Manolagas, S. C., and Jilka, R. L. Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: Influence on IL-6 production and osteoclast development. Bone Miner 24:109-126; 1994.
61. 61. Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, A., Tanaka, H., Ciliberto, G., Rodan, G. A., and Costantini, F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. Eur Mol Biol Org J 13:1189-1196; 1994.
62. 62. Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D., and Manolagas, S. C. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93:944-950; 1994.
63. 63. Romas, E., Udagawa, N., Zhou, H., Tamura, T., Saito, M., Taga, T., Hilton, D. J., Suda, T., Ng, K. W., and Martin, T. J. The role of gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 183:2581-2591; 1996.
64. 3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Endocrinology 138:4567-4571; 1997.
65. 65. Stein, B. and Yang, M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15:4971-4979; 1995.
66. 66. Steller, H. Mechanisms and genes of cellular suicide. Science 267:1445-1449; 1995.
67. 67. Stepan, J. J., Lachman, M., Zverina, J., Pacovsky, V., and Baylink, D. J. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 69:523-527; 1989.
68. 68. Suda, T., Udagawa, N., and Takahashi, N. Cells of bone: Osteoclast generation. In: Bilezikian, J. P., Raisz, L., and Rodan, G. A., Eds. Principals of Bone Biology. San Diego, CA: Academic; 1996; 87-102.
69. 69. Sunyer, T., Lewis, J., and Osdoby, P. Estrogen decreases the steady state levels of the IL-1 signaling receptor (Type I) while increasing those of the IL-1 decoy receptor (Type II) mRNAs in human osteoclast-like cells. J Bone Miner Res 12(Suppl. 1):S135; 1997.
70. 70. Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., and Gillespie, M. T. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185:1005-1012; 1997.
71. 71. Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Tada, T., Kishimoto, T., and Suda, T. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468; 1995.
72. 72. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-kappaB. Science 274:787-789; 1996.
73. 73. Vanderschueren, D., Van Herck, E., Nijs, J., Ederveen, A. G., De Coster, R., and Bouillon, R. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 138:2301-2307; 1997.
74. 74. Vanderschueren, D., Van Herck, E., Suiker, A. M. H., Visser, W. J., Schot, L. P. C., and Bouillon, R. Bone and mineral metabolism in aged male rats: Short and long term effects of androgen deficiency. Endocrinology 130:2906-2916; 1992.
75. 75. Wakley, G. K., Schutte, H. D., Jr., Hannon, K. S., and Turner, R. T. Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J Bone Miner Res 6:325-330; 1991.
76. 76. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology 138:4013-4021; 1997.
77. 77. Weiss, L. Bone marrow. In: Weiss, L., Ed. Cell and Tissue Biology. Baltimore: Urban and Schwarzenberg; 1988; 469-478.
78. 78. Yamashita, T., Ishii, H., Shimoda, K., Sampath, T. K., Katagiri, T., Wada, M., Osawa, T., and Suda, T. Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4. Bone 19:429-436; 1996.
79. 79. Yamate, T., Mocharla, H., Taguchi, Y., Igietseme, J. U., Manolagas, S. C., and Abe, E. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: Demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. Endocrinology 138:3047-3055; 1997.
80. 80. Yamazaki, K. and Eyden, B. P. A study of intercellular relationships between trabecular bone and marrow stromal cells in the murine femoral metaphysis. Anat Embryol (Berlin) 192:9-20; 1995.
81. 81. Yang, N. N., Bryant, H. U., Hardikar, S., Sato, M., Galvin, R. J. S., Glasebrook, A. L., and Termine, J. D. Estrogen and raloxifene stimulate transforming growth factor-β3 gene expression in rat bone: A potential mechanism for estrogen-or raloxifene-mediated bone maintenance. Endocrinology 137:2075-2084; 1996.
82. 82. Yang, N. N., Venugopalan, M., Hardikar, S., and Glasebrook, A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222-1225; 1996.
83. 83. Yang, N. N., Venugopalan, M., Hardikar, S., and Glasebrook, A. Correction: Raloxifene response needs more than an element [letter]. Science 275:1249; 1997.
84. 84. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinoshaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci 95:3597-3602; 1998.
85. 85. Zhou, H., Choong, P. C., Chou, S. T., Kartsogiannis, V., Martin, T. J., and Ng, K. W. Transforming growth factor β1 stimulates bone formation and resorption in an in vivo model in rabbits. Bone 17(Suppl.):443S-448S; 1995.